United Therapeutics Corp (UTHR)
380.35
+3.55
(+0.94%)
USD |
NASDAQ |
Nov 05, 11:41
United Therapeutics Max Drawdown (5Y): 57.86% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 57.86% |
| September 30, 2024 | 57.86% |
| August 31, 2024 | 57.86% |
| July 31, 2024 | 58.47% |
| June 30, 2024 | 58.47% |
| May 31, 2024 | 58.47% |
| April 30, 2024 | 60.30% |
| March 31, 2024 | 60.30% |
| February 29, 2024 | 60.30% |
| January 31, 2024 | 60.30% |
| December 31, 2023 | 60.30% |
| November 30, 2023 | 60.30% |
| October 31, 2023 | 60.30% |
| September 30, 2023 | 60.30% |
| August 31, 2023 | 60.30% |
| July 31, 2023 | 60.30% |
| June 30, 2023 | 60.30% |
| May 31, 2023 | 60.30% |
| April 30, 2023 | 60.30% |
| March 31, 2023 | 60.30% |
| February 28, 2023 | 60.30% |
| January 31, 2023 | 60.30% |
| December 31, 2022 | 60.30% |
| November 30, 2022 | 60.30% |
| October 31, 2022 | 60.30% |
| Date | Value |
|---|---|
| September 30, 2022 | 60.30% |
| August 31, 2022 | 60.30% |
| July 31, 2022 | 60.30% |
| June 30, 2022 | 60.30% |
| May 31, 2022 | 60.30% |
| April 30, 2022 | 60.30% |
| March 31, 2022 | 60.30% |
| February 28, 2022 | 60.30% |
| January 31, 2022 | 60.30% |
| December 31, 2021 | 60.30% |
| November 30, 2021 | 60.30% |
| October 31, 2021 | 60.30% |
| September 30, 2021 | 60.30% |
| August 31, 2021 | 60.30% |
| July 31, 2021 | 60.30% |
| June 30, 2021 | 60.30% |
| May 31, 2021 | 60.30% |
| April 30, 2021 | 60.30% |
| March 31, 2021 | 60.30% |
| February 28, 2021 | 60.30% |
| January 31, 2021 | 60.30% |
| December 31, 2020 | 60.30% |
| November 30, 2020 | 60.30% |
| October 31, 2020 | 60.30% |
| September 30, 2020 | 60.30% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
57.86%
Minimum
Aug 2024
60.30%
Maximum
Nov 2019
60.09%
Average
60.30%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Liquidia Corp | 93.87% |
| Pfizer Inc | 54.78% |
| Tonix Pharmaceuticals Holding Corp | 100.00% |
| Ardelyx Inc | 95.33% |
| Entrada Therapeutics Inc | -- |